-
Efficacy and safety of lenacapavir containing regimens in highly experienced HIV-infected patients with multidrug-resistance: real-word results from the French Compassionate Use Program
-
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study
-
Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity
-
Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort
-
Use of Isavuconazole in the Treatment of Cryptococcosis: A Real-World Case Series
-
Demographic, Clinical, Radiological, and Surgical Outcome of Patients with Intestinal Tuberculosis: A Single-Center Retrospective Study
-
Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study
-
Refractory mucocutaneous infections by herpes simplex virus (HSV) in hematopoietic cell transplant recipients: A real-world, multicenter study
-
Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat’AIDS Cohort)
-
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study
-
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study
-
Extreme cardiovascular risk and LDL-C target achievement in people with HIV
-
Prevalence of Hepatitis B co-infection in people with HIV by birth cohort
-
Candida auris Colonization in Hospitalized Patients at a Tertiary Care Center in Saudi Arabia: Clinical Characteristics, Predictors, and Outcomes
-
Real-world Impact of HPV Vaccination on CIN2+ Reduction: A Meta-Analysis of Observational Studies Assessing Variation by Age, Coverage, and Vaccine Type
-
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya
-
HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort
-
Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple Myeloma
-
“Effect of Non-Nucleoside Resistance Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights from the Real-World RELATIVITY Cohort”
-
Seroprevalence and Risk Factors for Toxoplasma gondii Infection in People Living with HIV: A Cross-Sectional Study from Maputo Central Hospital, Mozambique
-
Intravenous proton pump inhibitor uses for stress ulcer prophylaxis in the critically ill: a single-center study in Pakistan
-
Experiences and perceptions on diagnostic delay of leprosy by affected people in Colombia: A qualitative study
-
Clinical Characteristics and Molecular Epidemiology of Invasive Nontypeable Haemophilus influenzae at a Tertiary Medical Center in Washington, DC
-
Determinants of Fear of Cancer Recurrence and Development of a Nomogram-Based Risk Prediction Model in Patients with Primary Liver Cancer: A Single-Center Cross-Sectional Study
